Spear Pharmaceuticals is a specialty pharmaceutical company focused in the dermatology market. We develop branded and bioequivalent products that help people restore their skin's health. We manufacture our products in the United States in facilities inspected and approved by the FDA. Our commitment to quality has resulted in FDA approval for seven first-to-market bioquivalent dermatologicals, with several more in the pipeline.
View Top Employees from Spear PharmaceuticalsWebsite | http://www.spearpharma.com |
Revenue | $7 million |
Funding | $8.5 million |
Employees | 4 (4 on RocketReach) |
Founded | 1993 |
Address | 1250 Sussex Tpke, Ste G, Randolph, New Jersey 07869, US |
Phone | (973) 895-6447 |
Technologies |
JavaScript,
HTML,
Twitter
+7 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Drug Manufacturing & Research, Medical Device, Pharmaceuticals, Health Care, Healthcare, Pharmaceutical |
Web Rank | 24 Million |
Keywords | Tretinoin Sizes |
Competitors | Aclaris Therapeutics, Inc., Aprecia Pharmaceuticals, BioPharmX, Dusa Pharmaceuticals, Moleculin Biotech, Inc. |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Spear Pharmaceuticals employee's phone or email?
The Spear Pharmaceuticals annual revenue was $7 million in 2024.
Jonathan Barker is the Chairman and Co-Founder of Spear Pharmaceuticals.
4 people are employed at Spear Pharmaceuticals.
Spear Pharmaceuticals is based in Randolph, New Jersey.
The NAICS codes for Spear Pharmaceuticals are [3254, 32541, 32, 325].
The SIC codes for Spear Pharmaceuticals are [28, 283].